Rankings
▼
Calendar
ANIK FY 2012 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$204M
FY 2012 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$71M
+10.2% YoY
Gross Profit
$42M
59.4% margin
Operating Income
$20M
27.6% margin
Net Income
$12M
16.5% margin
EPS (Diluted)
$0.82
Cash Flow
Operating Cash Flow
$11M
Free Cash Flow
$9M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$142M
Total Liabilities
$33M
Stockholders' Equity
$109M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$71M
$65M
+10.2%
Gross Profit
$42M
$38M
+11.5%
Operating Income
$20M
$14M
+41.2%
Net Income
$12M
$8M
+38.9%
← FY 2011
All Quarters
FY 2013 →